바이오의약품 CMO 및 CRO 시장 : 공급원별, 서비스별, 제품별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)
Biopharmaceutical CMO and CRO Market, By Source, By Service, and By Product, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
상품코드
:
1330122
리서치사
:
Coherent Market Insights
발행일
:
2023년 06월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
바이오의약품 CMO(의약품 제조수탁기관)는 바이오의약품 분야의 다른 기업에게 의약품 제조 서비스부터 포장까지를 위탁하는 기업입니다. 반면, CRO(의약품개발수탁기관)는 연구업무를 위탁받아 바이오제약기업을 지원하는 기업입니다.
시장 역학:
만성질환 증가, 신약개발 증가, 바이오의약품 및 바이오시밀러 수요 증가, 아웃소싱 증가 추세, R&D 투자 증가, 바이오의약품 산업의 급격한 성장 등이 세계 바이오의약품 CMO/CRO 시장의 성장을 촉진하는 주요 요인입니다.
예를 들어 2023년 2월 루나포어와 Sirona Dx는 전략적 제휴를 발표했으며, Sirona Dx는 루나포어의 주력 제품인 COMET 공간 생물학 플랫폼을 서비스로 제공하는 미국 최초의 CRO가 될 것입니다. COMET은 다양한 분야의 연구자 및 바이오제약 팀의 요구를 충족시키기 위해 Sirona Dx의 연구 서비스 포트폴리오를 보완하며, 다양한 분야와 연구 및 의약품 개발의 모든 단계에서 광범위한 조사 용도을 제공합니다.
본 조사의 주요 특징
- 이 보고서는 세계 바이오의약품 CMO 및 CRO 시장을 상세하게 분석하여 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 연평균 성장률(CAGR)을 제시하였습니다.
- 또한 다양한 부문에서 잠재적인 매출 기회를 파악하고 이 시장에 대한 매력적인 투자 제안의 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 중요한 고려 사항도 제공합니다.
- 세계 바이오의약품 CMO 및 CRO 시장의 주요 기업 개요을 기업 하이라이트, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등의 매개 변수를 기반으로 분석합니다.
- 이번 조사 대상 주요 기업으로는 AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc. Accumedix, Inc. Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, Alliance for Clinical Trials in Oncology 등이 있습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 바이오 의약품 CMO 및 CRO 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계 바이오의약품 CMO 및 CRO 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 개요
- 리포트 개요
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 세계의 아웃소싱 동향의 증가
- 엄격한 규제 프레임워크
- 바이오의약품 산업의 급성장
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter의 산업 분석
- 합병·인수 시나리오
제4장 세계의 바이오의약품 CMO·CRO 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측 분석
- 경제적 영향
제5장 세계의 바이오의약품 CMO·CRO 시장 : 공급원별, 2023-2030년
제6장 세계의 바이오의약품 CMO·CRO 시장 : 서비스별, 2023-2030년
제7장 세계의 바이오의약품 CMO·CRO 시장 : 제품별, 2023-2030년
제8장 세계의 바이오의약품 CMO·CRO 시장 : 지역별, 2023-2030년
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- Allphase Clinical Research
- AlcheraBio
- Alcami
- Akos Urgent Care
- Agilent
- AGC Biologics
- Affinity Life Sciences, Inc.
- Actimus Bio
- ACI Clinical
- Accumedix, Inc.
- Absorption Systems
- A10 Clinical Solutions
- Albuquerque Clinical Trials(ACT)
- Ajinomoto Bio-Pharma Services
- Advanced Clinical Services LLC
- ACM Global Laboratories
- Accelerated Enrollment Solutions
- AbbVie Contract Manufacturing
- Advanced BioScience Laboratories
- Advanced Clinical Research Institute
- Alliance for Clinical Trials in Oncology
제10장 섹션
KSA
영문 목차
Biopharmaceutical CMO (Contract Manufacturing Organization) is a company that serves other companies in the biopharmaceutical sector on a contract basis to offer services ranging from drug manufacturing services to packaging. While, Contract Research Organization (CRO) is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis.
Market Dynamics:
Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand for biologics and biosimilars, growing trend of outsourcing, increasing investment in research and development and the rapid growth of the biopharmaceutical industry are major factors expected to augment the growth of the global biopharmaceutical CMO and CRO market.
For instance, in February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore's flagship COMET spatial biology platform as a service. A COMET will complement Sirona Dx's portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines. COMET has a wide range of research applications across multiple disciplines and all stages of research and drug development.
Key features of the study:
- This report provides in-depth analysis of the global biopharmaceutical CMO and CRO market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global biopharmaceutical CMO and CRO market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global biopharmaceutical CMO and CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical CMO and CRO market.
Detailed Segmentation:
- Global Biopharmaceutical CMO and CRO Market, By Source:
- Global Biopharmaceutical CMO and CRO Market, By Service:
- Contract Manufacturing
- Contract Research
- Global Biopharmaceutical CMO and CRO Market, By Product:
- Global Biopharmaceutical CMO and CRO Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles:
- Allphase Clinical Research
- AlcheraBio
- Alcami
- Akos Urgent Care
- Agilent
- AGC Biologics
- Affinity Life Sciences, Inc.
- Actimus Bio
- ACI Clinical
- Accumedix, Inc.
- Absorption Systems
- A10 Clinical Solutions
- Albuquerque Clinical Trials (ACT)
- Ajinomoto Bio-Pharma Services
- Advanced Clinical Services LLC
- ACM Global Laboratories
- Accelerated Enrollment Solutions
- AbbVie Contract Manufacturing
- Advanced BioScience Laboratories
- Advanced Clinical Research Institute
- Alliance for Clinical Trials in Oncology
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Service
- Market Snapshot, By Product
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing trend of outsourcing across the globe
- Stringent regulatory framework
- Rapid growth of the biopharmaceutical industry
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Biopharmaceutical CMO and CRO Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Biopharmaceutical CMO and CRO Market, By Source, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Non-mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Biopharmaceutical CMO and CRO Market, By Service, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Contract Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Contract Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
7. Global Biopharmaceutical CMO and CRO Market, By Product, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
8. Global Biopharmaceutical CMO and CRO Market, By Region, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
9. Competitive Landscape
- Allphase Clinical Research
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AlcheraBio
- Alcami
- Akos Urgent Care
- Agilent
- AGC Biologics
- Affinity Life Sciences, Inc.
- Actimus Bio
- ACI Clinical
- Accumedix, Inc.
- Absorption Systems
- A10 Clinical Solutions
- Albuquerque Clinical Trials (ACT)
- Ajinomoto Bio-Pharma Services
- Advanced Clinical Services LLC
- ACM Global Laboratories
- Accelerated Enrollment Solutions
- AbbVie Contract Manufacturing
- Advanced BioScience Laboratories
- Advanced Clinical Research Institute
- Alliance for Clinical Trials in Oncology
- Analyst Views
10. Section
- Research Methodology
- About us
관련자료
